A carregar...
Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen Receptor
Prostate cancer is the leading cause of cancer and second leading cause of cancer-related death in men in the United States. Twenty percent of patients receiving the standard of care androgen deprivation therapy (ADT) eventually progress to metastatic and incurable castration-resistant prostate canc...
Na minha lista:
| Publicado no: | Assay Drug Dev Technol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Mary Ann Liebert, Inc., publishers
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6921095/ https://ncbi.nlm.nih.gov/pubmed/31502857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/adt.2019.940 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|